Published in
Lippincott, Williams & Wilkins, Obstetrical & Gynecological Survey, 5(77), p. 275-276, 2022
DOI: 10.1097/ogx.0000000000001032
Cancer Research, Statistics, and Treatment, 2(5), p. 351, 2022
Massachusetts Medical Society, New England Journal of Medicine, 2022
Links
Tools
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
Journal article published in 2022 by
Vicky Makker,
Antonio Casado Herráez,
Alessandro D. Santin,
David S. Miller 
,
Sandro Pignata,
Kimio Ushijima,
Isabelle Ray-Coquard,
Nicoletta Colombo,
Ronnie Shapira-Frommer,
Kan Yonemori,
Jun Sakata,
Emeline Colomba,
Yong Man Kim,
Keiichi Fujiwara,
Ulus A. Sanli
and other authors.
,
Sandro Pignata,
Kimio Ushijima,
Isabelle Ray-Coquard,
Nicoletta Colombo,
Ronnie Shapira-Frommer,
Kan Yonemori,
Jun Sakata,
Emeline Colomba,
Yong Man Kim,
Keiichi Fujiwara,
Ulus A. Sanli
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 